TransMedics Group, Inc. (TMDX) Financial Overview
Deep analysis for TMDX is on the way!
Due to high demand, our research team is working through a large queue of in-depth reports. In the meantime, feel free to explore the financial data below. For questions or specific requests, reach out to support@graphvest.com.
TMDX Price Action & Catalysts
Revenue & EPS Trend
Revenue & EPS Growth
Financial Snapshot
| Metric | Latest Annual | YoY |
|---|---|---|
| Revenue | $605.49M | ↑37.1% |
| Net Income | $190.29M | ↑436.6% |
| EPS (Diluted) | 4.87 | ↑382.2% |
| Free Cash Flow | $133.59M | ↑265.0% |
| Total Debt | $469.69M | ↓9.4% |
| Total Equity | $473.10M | ↑107.0% |
Earnings Surprise
Earnings Surprise History
Peer Comparison
Peer Valuation Comparison
Margin Trends
Margin Trends